Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively.
Acipimox (K-9321) is a nicotinic acid analogue with anti-lipid and anti-lipolysis effects. Acipimox can acutely inhibit lipolysis, inhibit free fat levels throughout the body and improve insulin sensitivity.
Acipimox (K-9321) is a nicotinic acid analogue with anti-lipid and anti-lipolysis effects. Acipimox can acutely inhibit lipolysis, inhibit free fat levels throughout the body and improve insulin sensitivity.